The effect of grapefruits (Citrus paradisi) on body weight and cardiovascular risk factors: A systematic review and meta-analysis of randomized clinical trials

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 3, 2017, Pages 602-612

  Onakpoya, Igho ^a   O’Sullivan, Jack ^a   Heneghan, Carl ^a   Thompson, Matthew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

body composition; body weight; Grapefruit; meta analysis; randomized clinical trial

Indexed keywords

ANTHROPOMETRY; BIOCHEMISTRY; BLOOD PRESSURE; CITRUS FRUITS; MEDICAL APPLICATIONS;

BODY COMPOSITION; BODY WEIGHT; GRAPEFRUIT; META ANALYSIS; RANDOMIZED CLINICAL TRIALS;

RISK ASSESSMENT;

CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASE; FACTUAL DATABASE; GLUCOSE BLOOD LEVEL; GRAPEFRUIT; HUMAN; META ANALYSIS; METABOLISM; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASES; CHOLESTEROL; CITRUS PARADISI; DATABASES, FACTUAL; HUMANS; OBESITY; OVERWEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84992735566     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2014.901292     Document Type: Article

References (51)

1. A.A.Adeneye, (2008). Methanol seed extract of Citrus paradisi Macfad lowers blood glucose, lipids and cardiovascular disease risk indices in normal Wistar rats. Nig. Q. J. Hosp. Med. 18(1):16–20.
2. A.Q.Adigun, and Z.Mudasiru,. (2002). Clinical effects of grapefruit juice-nifedipine interaction in a 54-year-old Nigerian:A case report. J. Natl. Med. Assoc. 94(4):276–278.
3. O.M.Ahmed, A.A.Mahmoud, A.Abdel-Moneim, and M.B.Ashour, (2012). Antidiabetic effects of hesperidin and naringin in type 2 diabetic rats. Diabetol. Croat. 41–42:53–67.
4. D.G.Bailey, J.Malcolm, O.Arnold and J.D.Spence, (1998). Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol. 46:101–110.
5. D.G.Bailey, J.D.Spence, B.Edgar, C.D.Bayliff, and J.M.Arnold, (1989). Ethanol enhances the hemodynamic effects of felodipine. Clin. Invest. Med. 12(6):357–362.
6. D.G.Bailey, J.D.Spence, C.Munoz, and J.M.Arnold, (1991). Interaction of citrus juices with felodipine and nifedipine. Lancet. 337:268--269.
7. J.Barona, J.C.Aristizabal, C.N.Blesso, J.S.Volek, and M.L.Fernandez, (2012b). Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J. Nutr. 142(9):1626–1632.
8. J.Barona, C.N.Blesso, C.J.Andersen, Y.Park, J.Lee, and M.L.Fernandez, (2012a). Grape consumption increases anti-inflammatory markers and upregulates peripheral nitric oxide synthase in the absence of dyslipidemias in men with metabolic syndrome. Nutrients. 4:1945–1957.
9. O.Benavente-Garcia, and J.Castillo, (2008). Updates on uses and properties of Citrus flavonoids:New findings in anticancer, cardiovascular and anti-inflammatory activity. J. Agric. Food Chem. 56:6185–6205.
10. A.L.Blum, J.Hegglin, G.J.Krejs, F.Largiadèr, H.Säuberli, and P.Schmid, (1976). Gastric emptying of organic acids in the dog. J. Physiol. 261:285–299.
11. R.P.Bolton, K.W.Heaton, and L.F.Burroughs, (1981). The role of dietary fiber in satiety, glucose, and insulin:Studies with fruit and fruit juice. Am. J. Clin. Nutr. 34(2):211–217.
12. S.Carrington, and H.C.Fraser, (2003). “Grapefruit.” A∼Z of Barbados Heritage. Macmillan Caribbean, pp. 90–91.
13. J.J.Cerda, F.L.Robbins, C.W.Burgin, T.G.Baumgartner, and R.W.Rice, (1988). The effects of grapefruit pectin on patients at risk for coronary heart disease without altering diet or lifestyle. Clin. Cardiol. 11(9):589–594.
14. C.S.Chaw, E.Yazaki, and D.F.Evans, (2001). The effect of pH on the gastric emptying of liquids measured by electrical impedance tomography and pH-sensitive radiotelemetry capsule. Int. J. Pharm. 227:167–175.
15. K.W.Cho, Y.O.Kim, J.E.Andrade, J.R.Burgess, and Y.C.Kim, (2011). Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats. Eur. J. Nutr. 50:81–88.
16. C.Dallas, A.Gerbi, G.Tenca, F.Juchaux, and F.X.Bernard, (2008). Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). Phytomedicine. 15(10):783–792.
17. J.J.Deeks, J.P.T.Higgins, and D.G.Altman, (Editors). (2011). Chapter 9:Analysing data and undertaking meta-analyses. In:Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. J.P.T.Higgins, and S.Green, Eds., The Cochrane Collaboration. Available from www.cochrane-handbook.org.
18. I.Demonty, Y.Lin, Y.E.Zebregs, M.A.Vermeer, H.C.van der Knaap, M.Jäkel, and E.A.Trautwein, (2010). The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J. Nutr. 140(9):1615–1620.
19. J.A.Díaz-Juárez, F.A.Tenorio-López, G.Zarco-Olvera, L.D.Valle-Mondragón, J.C.Torres-Narváez, and G.Pastelín-Hernández, (2009). Effect of Citrus paradisi extract and juice on arterial pressure both in vitro and in vivo. Phytother. Res. 23(7):948–954.
20. C.A.Dow, S.B.Going, H.H.Chow, B.S.Patil, and C.A.Thomson, (2012). The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults. Metabolism. 61(7):1026–1035.
21. K.Fujioka, F.Greenway, J.Sheard, and Y.Ying, (2006). The effects of grapefruit on weight and insulin resistance:Relationship to the metabolic syndrome. J. Med. Food. 9(1):49–54.
22. M.Ganzera, A.Aberham, and H.Stuppner, (2006). “Development and validation of an HPLC/UV/MS method for simultaneous determination of 18 preservatives in grapefruit seed extract”. J. Agric. Food Chem. 54(11):3768–3772.
23. J.S.Grundy, L.A.Eliot, K.M.Kulmatycki, and R.T.Foster, (1998). Grapefruit juice and orange juice effects on the bioavailability of nifedipine in the rat. Biopharm. Drug. Dispos. 19(3):175–183.
24. G.H.Guyatt, A.D.Oxman, G.E.Vist, R.Kunz, Y.Falck-Ytter, P.Alonso-Coello, H.J.Schünemann, and GRADE Working Group. (2008). GRADE:An emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 336:924–926.
25. J.P.T.Higgins, J.J.Deeks, D.G.Altman, on behalf of the Cochrane Statistical Methods Group. (Editors). (2011). Chapter 16:General principles for dealing with missing data. In:Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. J.P.T.Higgins, and S.Green, Eds., The Cochrane Collaboration. Available from www.cochrane-handbook.org.
26. P.C.Ho, and D.J.Saville, (2001). Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J. Pharm. Pharmaceut. Sci. 4:217–227.
27. U.J.Jung, H.J.Kim, J.S.Lee, M.K.Lee, H.O.Kim, E.J.Park, H.K.Kim, T.S.Jeong, and M.S.Choi, (2003). Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin. Nutr. 22:561–568.
28. F.I.Kanaze, M.I.Bounnartzi, M.Georgarakis, and I.Niopas, (2007). Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr. 61:472--477.
29. C.A.Lans, (2006). Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J. Ethnobiol. Ethnomed. 2:45. DOI:10.1186/1746-4269-2-45.
30. M.Li, and A.E.Hagerman, (2013). Interactions between plasma proteins and naturally occurring polyphenols. Curr. Drug. Metab. 14(4):432–445.
31. J.J.Lilja, K.T.Kivistö, and P.J.Neuvonen, (1998). Grapefruit juice-simvastatin interaction:Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin. Pharmacol. Ther. 64(5):477–483.
32. C.Manach, G.Williamson, C.Morand, A.Scalbert, and C.Rémésy, (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81(suppl):230S–242S.
33. K.Nakagawa, and T.Goto, (2010). Effects of ingestion of grapefruit juice or grapefruit on the hypotensive effect and plasma concentrations of dihydropyridine calcium antagonists (amlodipine and nifedipine):A case study. Clin. Exp. Hypertens. 32(2):71–75.
34. P.Odou, N.Ferrari, C.Barthélémy, S.Brique, M.Lhermitte, A.Vincent, C.Libersa, and H.Robert, (2005). Grapefruit juice-nifedipine interaction:Possible involvement of several mechanisms. J. Clin. Pharm. Ther. 30(2):153–158.
35. I.J.Onakpoya, B.Wider, M.H.Pittler, and E.Ernst, (2011). Food supplements for body weight reduction:A systematic review of systematic reviews. Obesity. 19(2):239–244.
36. P.M.Owira, and J.A.Ojewole, (2009). Grapefruit juice improves glycemic control but exacerbates metformin-induced lactic acidosis in non-diabetic rats. Methods. Find. Exp. Clin. Pharmacol. 31(9):563–570.
37. J.J.Peterson, G.R.Beecher, S.A.Bhagwat, J.T.Dwyer, S.E.Gebhardt, D.B.Haytowitz, and J.M.Holden, (2006). Flavanones in grapefruit, lemons, and limes:A compilation and review of the data from analytical literature. J. Food Comp. Anal. 19:S74–S80.
38. M.Pirmohamed, (2013). Editorial. Drug-grapefruit juice interactions. BMJ. 346:f1. DOI:10.1136/bmj.f1.
39. P.Pu, D.-M.Gao, S.Mohamed, J.Chen, J.Zhang, X.-Y.Zhou, N.-J.Zhou, J.Xie, and H.Jiang, (2012). Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch. Biochem. Biophys. 518:61–70.
40. N.Reshef, Y.Hayari, C.Goren, M.Boaz, Z.Madar, and H.Knobler, (2005). Antihypertensive effect of sweetie fruit in patients with stage I hypertension. Am. J. Hypertens. 18:1360–1363.
41. Review Manager (RevMan) (2008). Review Manager (RevMan) [Computer Program]. Version 5.0. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen.
42. I.A.Ribeiro, and M.H.L.Ribeiro, (2008). Naringin and naringenin determination and control in grapefruit juice by a validated HPLC method. Food Control. 19:432–438.
43. R.B.Saper, D.M.Eisenberg, and R.S.Phillips, (2004). Common dietary supplements for weight loss. Am. Fam. Physician. 70(9):1731–1738.
44. A.Scalbert, C.Manach, C.Morand, C.Rémésy, and L.Jiménez, (2005). Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45(4):287–306.
45. K.F.Schulz, D.G.Altman, D.Moher, and for the CONSORT Group. (2010). CONSORT 2010 Statement:Updated Guidelines for Reporting Parallel Group Randomised Trials. PloS. Med. 7(3):e1000251.
46. A.K.Sharma, S.Bharti, S.Ojha, J.Bhatia, N.Kumar, R.Ray, S.Kumari, and D.S.Arya, (2011). Up-regulation of PPARγ, heat shock protein-27 and −72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br. J. Nutr. 106(11):1713–1723.
47. J.Shi, J.Yu, J.E.Pohorly, and Y.Kakuda, (2003). Polyphenolics in grape seeds-biochemistry and functionality. J. Med. Food. 6(4):291–299.
48. H.J.Silver, M.S.Dietrich, and K.D.Niswender, (2011). Effects of grapefruit, grapefruit juice and water preloads on energy balance, weight loss, body composition, and cardiometabolic risk in free-living obese adults. Nutr. Metab. (Lond). 8(1):8. doi:10.1186/1743-7075-8-8
49. World Health Organisation. (2013). Obesity and Overweight Fact sheet No 311. Available from http://www.who.int/mediacentre/factsheet. Accessed April2, 2013.
50. T.L.Zern, R.J.Wood, C.Greene, K.L.West, Y.Liu, D.Aggarwal, N.S.Shachter, and M.L.Fernandez,. (2005). Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J. Nutr. 135:1911–1917.
51. S.Zunino, (2009). Type 2 diabetes and glycemic response to grapes or grape products. J. Nutr. 139(9):1794S–800S.